Skip to main content

1 Result(s)

within Melyssa S. Roberts Remove this filter

and

  1. Article

    Open Access

    KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene

    Triple-negative breast cancer (TNBC) is characterized by high rates of recurrence and poor overall survival. This is due, in part, to a deficiency of targeted therapies, making it essential to identify therape...

    Melyssa S. Roberts, Lindsey J. Anstine, Viviane S. Finke… in Breast Cancer Research (2020)

    Download PDF (1463 KB) View Article